UK Study Indicates That The Cardiovascular Risk Of Celebrex No Different From Other Pain Drugs

But for those free of cardiovascular disease, Celebrex appears to offer no increased cardiovascular risk compared to traditional NSAIDs like ibuprofen and diclofenac. Many would have bet against such an outcome 10 years ago.

Source: Forbes.com Healthcare News - September 3, 2015 Category: Pharmaceuticals Authors: John LaMattina Source Type: news